325 related articles for article (PubMed ID: 25769364)
1. [Cystinosis in adults: A systemic disease].
Servais A; Goizet C; Bertholet-Thomas A; Decramer S; Llanas B; Choukroun G; Novo R
Nephrol Ther; 2015 Jun; 11(3):152-9. PubMed ID: 25769364
[TBL] [Abstract][Full Text] [Related]
2. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
Nesterova G; Williams C; Bernardini I; Gahl WA
Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
[TBL] [Abstract][Full Text] [Related]
3. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
[TBL] [Abstract][Full Text] [Related]
4. [Cystinosis : Diagnosis, cystine-depleting therapy, and transition].
Kaufeld J; Weber LT; Kurschat C; Canaan-Kuehl S; Brand E; Oh J; Pape L
Internist (Berl); 2018 Aug; 59(8):861-867. PubMed ID: 29671012
[TBL] [Abstract][Full Text] [Related]
5. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
[TBL] [Abstract][Full Text] [Related]
6. [Peculiarity of infantile cystinosis in Tunisian children].
Jellouli M; Ben Turkia H; Abidi K; Hammi Y; Gargah T
Pan Afr Med J; 2015; 22():348. PubMed ID: 26985266
[TBL] [Abstract][Full Text] [Related]
7. Follow-up and treatment of adults with cystinosis in the Netherlands.
Geelen JM; Monnens LA; Levtchenko EN
Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
[TBL] [Abstract][Full Text] [Related]
8. [Improved prognosis of cystinosis achieved by treatment with cysteamine and by kidney transplantation].
Oczachowska-Kulik AE; Lund AM; Skovby F; Pedersen EB
Ugeskr Laeger; 2011 Aug; 173(33):1958-62. PubMed ID: 21849135
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of infantile nephropathic cystinosis with cysteamine.
da Silva VA; Zurbrügg RP; Lavanchy P; Blumberg A; Suter H; Wyss SR; Lüthy CM; Oetliker OH
N Engl J Med; 1985 Dec; 313(23):1460-3. PubMed ID: 4058549
[No Abstract] [Full Text] [Related]
10. Nephropathic cystinosis: late complications of a multisystemic disease.
Nesterova G; Gahl W
Pediatr Nephrol; 2008 Jun; 23(6):863-78. PubMed ID: 18008091
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term cysteamine treatment in patients with cystinosis.
Ariceta G; Giordano V; Santos F
Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
[TBL] [Abstract][Full Text] [Related]
12. Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.
Berryhill A; Bhamre S; Chaudhuri A; Concepcion W; Grimm PC
Pediatr Transplant; 2016 Feb; 20(1):141-5. PubMed ID: 26477696
[TBL] [Abstract][Full Text] [Related]
13. Extrarenal complications of cystinosis.
Topaloglu R
Pediatr Nephrol; 2024 Aug; 39(8):2283-2292. PubMed ID: 38127152
[TBL] [Abstract][Full Text] [Related]
14. Infantile cystinosis: From dialysis to renal transplantation.
Jellouli M; Ferjani M; Abidi K; Zarrouk C; Abdelmoula J; Gargah T
Saudi J Kidney Dis Transpl; 2017; 28(5):1180-1183. PubMed ID: 28937083
[TBL] [Abstract][Full Text] [Related]
15. The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.
Cherqui S; Courtoy PJ
Nat Rev Nephrol; 2017 Feb; 13(2):115-131. PubMed ID: 27990015
[TBL] [Abstract][Full Text] [Related]
16. Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.
Levtchenko EN; de Graaf-Hess A; Blom HJ; Monnens LA
Clin Nephrol; 2002 May; 57(5):349-51. PubMed ID: 12036193
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report.
Higashi S; Matsunoshita N; Otani M; Tokuhiro E; Nozu K; Ito S
BMC Nephrol; 2017 Sep; 18(1):300. PubMed ID: 28950840
[TBL] [Abstract][Full Text] [Related]
18. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.
Gahl WA; Balog JZ; Kleta R
Ann Intern Med; 2007 Aug; 147(4):242-50. PubMed ID: 17709758
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.
Hohenfellner K; Nießl C; Haffner D; Oh J; Okorn C; Palm K; Schlingmann KP; Wygoda S; Gahl WA
Mol Genet Metab; 2022 Aug; 136(4):282-288. PubMed ID: 35843134
[TBL] [Abstract][Full Text] [Related]
20. [From gene to disease: cystinosis].
Levtchenko EN; Wilmer M; de Graaf-Hess AC; van den Heuvel LP; Blom H; Monnens LA
Ned Tijdschr Geneeskd; 2004 Mar; 148(10):476-8. PubMed ID: 15042893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
